US PTAB Patent Cases
5,620 decisions indexed
Page 83 of 188 · 5,620 total
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
Samsung seeks to uphold an IPR institution on Wilus’s Wi‑Fi packet‑format patent, while Wilus requests Director Review to overturn the institution, arguing errors on public accessibility, discretionary denial, and claim‑construction inconsistency.
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
The USPTO denied Samsung's request for Director Review of the institution decisions in several IPRs involving Wilus's patent 11,159,210. The institution decisions remain in effect.
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
Wilus sought leave to address recent director‑review decisions and submit new evidence in five IPRs, but the Director denied the request, citing policy against inconsistent claim constructions and statutory timing constraints.
Apple Inc. v.Apex Beam Technologies LLC
Apple and Apex Beam Technologies entered a settlement that led to the joint termination of sixteen inter partes review proceedings, including IPR2025-00898 covering patent 10,951,271. The Board granted the motion to terminate under 35 U.S.C. § 317.
Apple Inc. v.Apex Beam Technologies LLC
Apple’s IPR petition was granted, instituting review of all 20 claims of Apex Beam’s 5G paging patent. The Board found a reasonable likelihood of unpatentability based on prior art You, Liu, and Mallick.
Samsung Electronics Co., Ltd. et al. v.Hermes IP Management LLC
Samsung and Hermes IP Management settled their IPR dispute over U.S. Patent 9,613,060 before the Board instituted a trial. The Board granted the parties' motions to terminate and treated the settlement agreement as confidential.
Apple Inc. v.Apex Beam Technologies LLC
Apple and Apex Beam have reached a confidential settlement and jointly moved to terminate the IPR concerning Apex Beam’s multi‑antenna transmission patent (U.S. 10,951,271). The motion cites compliance with 35 U.S.C. §317 and argues that termination serves public policy.
Google LLC v.Sandpiper CDN, LLC
Kaifi LLC and Amazon reached a settlement, filing a joint motion to stay court deadlines while they finalize the agreement.
Docker Inc. v.Intellectual Ventures II LLC
Docker Inc. and Intellectual Ventures II LLC settled their inter partes review disputes before trial, leading the PTAB to dismiss the IPRs. The settlement covered three patents and the agreements were treated as confidential business information.
Apple Inc. v.Apex Beam Technologies LLC
Apple Inc. petitions the PTAB to invalidate claims 1‑20 of Apex Beam’s multi‑antenna transmission patent, asserting obviousness over Liu and Park publications. The petition details a predictable combination of prior‑art teachings and argues against discretionary denial.
Apple Inc. v.Apex Beam Technologies LLC
Apple has filed an IPR petition challenging Apex Beam’s 2019 patent covering paging methods in LTE/5G networks, asserting that all 20 claims are obvious over prior‑art standards and patents. The petition seeks institution of the review and argues that discretionary denial is unwarranted.
AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.
Azurity has filed an IPR petition seeking cancellation of 23 claims of Helsinn’s anti‑emetic patent covering netupitant, palonosetron and dexamethasone regimens. The challenger alleges obviousness over multiple prior‑art references and disputes the asserted unexpected synergy. No decision has been issued yet.
Apple Inc. v.Apex Beam Technologies LLC
Apple has filed an IPR petition seeking cancellation of 21 claims of Apex Beam’s paging patent (U.S. 11,917,581). The petition alleges obviousness over Yeo, 3GPP TS 36.304, and Mallick references and argues that discretionary denial is not warranted.
Google LLC v.Sandpiper CDN, LLC
Google has petitioned the PTAB to invalidate all 20 claims of Sandpiper CDN’s CDN patent, arguing anticipation by Newton-471 and obviousness over Dilley, Pai, and Wang. The petition stresses favorable institution factors and argues against discretionary denial.
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
Samsung has filed an IPR petition challenging U.S. Patent 11,159,210, asserting that all nine claims are obvious over the 802.11ax draft standard and two earlier patent publications. The petition relies on expert testimony and argues that the Board should not exercise discretionary denial.
AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.
AZURITY PHARMACEUTICALS successfully petitioned to institute IPR proceedings against Helsinn Healthcare S.A.'s anti-emetic patent (8623826). The Board found a reasonable likelihood of prevailing on independent claim 19, allowing the challenge based on obviousness over prior art like MASCC and Hoffmann.
AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.
AZURITY PHARMACEUTICALS, INC. successfully secured institution of its IPR against Helsinn Healthcare S.A.'s patent (9186357) for anti-emetic agents. The Board found a reasonable likelihood that several claims would be unpatentable over prior art, specifically regarding the combination of triple-drug CINV treatment and superior NK antagonists.
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
Samsung challenged Wilus's wireless patent claims based on obviousness in view of prior art standards and publications. The PTAB institution decision found a reasonable likelihood that the claims are unpatentable, specifically citing combinations of Bharadwaj and Sun. This sets up a significant trial over HE WLAN technology.
Docker Inc. v.Intellectual Ventures II LLC
The USPTO Board denied the institution of IPR2025-00840, favoring Intellectual Ventures II LLC's request for discretionary denial. The decision cited parallel district court and IPR proceedings as reasons to conserve resources.
Shenzhen Fbtech Electronics Ltd. et al. v.LithiumHub Technologies, LLC
Shenzhen FBTech and LiTime settled their IPR against LithiumHub's battery‑technology patent before trial, prompting the PTAB to terminate the proceeding and keep the settlement confidential.
Inter IKEA Systems B.V. v.POINTWISE VENTURES, LLC
Inter IKEA Systems and Pointwise Ventures settled their dispute over U.S. Patent 8,471,812, leading the PTAB to terminate the IPR before institution. The settlement agreement was ordered to be kept confidential under 37 C.F.R. § 42.74.
Shenzhen Fbtech Electronics Ltd. et al. v.LithiumHub Technologies, LLC et al.
Petitioners and the patent owner jointly filed a motion asking the PTAB to treat their settlement agreements as business confidential information, invoking 35 U.S.C. §317(b) and 37 C.F.R. §42.74(c). The request is presented as timely and compliant with the applicable statutes and regulations.
Shenzhen Fbtech Electronics Ltd. et al. v.LithiumHub Technologies, LLC et al.
The parties to IPR2025‑00825 settled their dispute over U.S. Patent 9,412,994 and jointly moved to terminate the inter partes review. The Board has not yet ruled on institution, and the motion cites statutory authority for termination.
Shenzhen Fbtech Electronics Ltd. et al. v.LithiumHub Technologies, LLC
LithiumHub Technologies and two Shenzhen firms settled IPR2025‑00822 concerning a solid‑state lithium battery patent, seeking dismissal of the proceeding.
Inter IKEA Systems B.V. v.POINTWISE VENTURES, LLC
IKEA and Pointwise jointly filed a motion requesting that their settlement agreement in IPR2025-00798 be treated as business confidential information, invoking 35 U.S.C. § 317(b). The Board’s decision on the confidentiality request is pending.
Inter IKEA Systems B.V. v.POINTWISE VENTURES, LLC
Inter IKEA Systems and Pointwise Ventures jointly moved to terminate IPR2025-00798 after settling their dispute over U.S. Patent 8,471,812. The Board is asked to dismiss the proceeding per settlement and statutory provisions.
Zhuhai CosMX Battery Co., Ltd. v.Ningde Amperex Technology Ltd.
The PTAB denied Zhuhai CosMX Battery’s petition to invalidate Ningde Amperex’s 2020 electrolyte patent, finding no reasonable likelihood of success. The Board held that the prior art did not adequately disclose all claim elements, especially the propyl propionate ratio.
Shenzhen Fbtech Electronics Ltd. et al. v.LithiumHub Technologies, LLC et al.
Shenzhen FBTech and LiTime settled their IPR challenge to LithiumHub's patent 9,412,994, leading the PTAB to terminate the proceeding before trial and keep the settlement confidential.
Amphenol Corporation v.Credo Technology Group Ltd.
Court decision.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol and Credo Technology settled four inter partes review proceedings, leading the PTAB to terminate the cases before trial.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.